Company intelligence / Profile preview

AmplifyBio

West Jefferson, Ohio, United Statesamplify-bio.com ↗

Ownership: Private
Development stage: Commercial

Overview

AmplifyBio was a leading preclinical CRO and CDMO specializing in next-generation therapies including cell, gene, mRNA-based drugs, and small molecules. The company provided discovery through IND-enabling studies with expertise in toxicology, safety assessments, manufacturing enablement services for advanced modalities, and modern data automation solutions. It ceased operations in April 2025 due to market downturns affecting early-stage cell and gene therapy development.

Therapeutic areas: Other
Modalities: Cell therapyGene therapymRNA-based drugsSmall molecule
Industry: Contract Research Organization

Partnerships

Academic institutionsbiopharma companies

Beyond the preview

Go deeper on AmplifyBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AmplifyBio.

Explore the full profile